Literature DB >> 25115371

Hypertrophic scars and keloids in surgery: current concepts.

Colin Song1.   

Abstract

Hypertrophic scars and keloids remain a challenge in surgery. We appreciate that our understanding of the process at cellular and molecular level, profound as it is, when it comes to the clinical evidence much is left to be desired. Although the bench to bedside conundrum remains, the science of translational research calls for an even higher level of cooperation between the scientist and the clinician for the impetus to succeed.The clinicians alerted us to the possible theories in the pathogenesis of keloid formation, inter alia, the ischemia theory, mast cell theory, immune theory, transforming growth factor β interaction, mechanical theory, and the melanocyte stimulating hormone theory. All of the above presupposed a stimulus that would result in an uncontrolled upregulation of collagen and extracellular matrix expression in the pathogenesis of the keloid. This bedside to bench initiative, as in true science, realized more ponderables than possibilities.By the same token, research into the epidermal-mesenchymal signaling, molecular biology, genomics, and stem cell research holds much promise in the bench top arena. To assess efficacy, many scar assessment scores exist in the literature. The clinical measurement of scar maturity can aid in determining end points for therapeutics. Tissue oxygen tension and color assessment of scars by standardized photography proved to be useful.In surgery, the use of dermal substitutes holds some promise as we surmise that quality scars that arise from dermal elements, molecular and enzyme behavior, and balance. Although a systematic review shows some benefit for earlier closure and healing of wounds, no such review exists at this point in time for the use of dermal substitutes in scars.Adipose-derived stem cell, as it pertains to scars, will hopefully realize the potential of skin regeneration rather than by repair in which we are familiar with as well as the undesirable scarring as a result of healing through the inflammatory response.Translational research will bear the fruit of coordinating bench to bedside and vice versa in the interest of progress into the field of regenerative healing that will benefit the patient who otherwise suffers the myriad of scar complications.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25115371     DOI: 10.1097/SAP.0000000000000256

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  13 in total

Review 1.  Wnt signaling induces epithelial differentiation during cutaneous wound healing.

Authors:  Khosrow S Houschyar; Arash Momeni; Malcolm N Pyles; Zeshaan N Maan; Alexander J Whittam; Frank Siemers
Journal:  Organogenesis       Date:  2015       Impact factor: 2.500

2.  Thy1 (CD90) Expression Is Elevated in Radiation-Induced Periprosthetic Capsular Contracture: Implication for Novel Therapeutics.

Authors:  Trevor C Hansen; Collynn F Woeller; Shannon H Lacy; Peter F Koltz; Howard N Langstein; Richard P Phipps
Journal:  Plast Reconstr Surg       Date:  2017-08       Impact factor: 4.730

3.  A Translational Animal Model for Scar Compression Therapy Using an Automated Pressure Delivery System.

Authors:  A Alkhalil; S Tejiram; T E Travis; N J Prindeze; B C Carney; L T Moffatt; L S Johnson; J Ramella-Roman; J W Shupp
Journal:  Eplasty       Date:  2015-07-02

Review 4.  The effectiveness of pressure therapy (15-25 mmHg) for hypertrophic burn scars: A systematic review and meta-analysis.

Authors:  Jin-Wei Ai; Jiang-Tao Liu; Sheng-Duo Pei; Yu Liu; De-Sheng Li; Hong-Ming Lin; Bin Pei
Journal:  Sci Rep       Date:  2017-01-05       Impact factor: 4.379

5.  Involvement of eIF6 in external mechanical stretch-mediated murine dermal fibroblast function via TGF-β1 pathway.

Authors:  Qin Shu; Jianglin Tan; Van Daele Ulrike; Xiaorong Zhang; Jiacai Yang; Sisi Yang; Xiaohong Hu; Weifeng He; Gaoxing Luo; Jun Wu
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

6.  Use of Hyaluronic Acid-Based Biological Bilaminar Matrix in Wound Bed Preparation: A Case Series.

Authors:  Richard Simman; Walid Mari; Sara Younes; Michael Wilson
Journal:  Eplasty       Date:  2018-02-22

7.  Paclitaxel reduces formation of hypertrophic scars in the rabbit ear model.

Authors:  Li-Ping Huang; Guo-Qi Wang; Zi-Shan Jia; Jing-Wen Chen; Gang Wang; Xing-Lin Wang
Journal:  Ther Clin Risk Manag       Date:  2015-07-27       Impact factor: 2.423

8.  Comparison between Stromal Vascular Fraction and Adipose Mesenchymal Stem Cells in Remodeling Hypertrophic Scars.

Authors:  Sophie Domergue; Claire Bony; Marie Maumus; Karine Toupet; Eric Frouin; Valérie Rigau; Marie-Catherine Vozenin; Guy Magalon; Christian Jorgensen; Danièle Noël
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

9.  Sorafenib exerts an anti-keloid activity by antagonizing TGF-β/Smad and MAPK/ERK signaling pathways.

Authors:  Wenbo Wang; Miao Qu; Lan Xu; Xiaoli Wu; Zhen Gao; Tingyu Gu; Wenjie Zhang; Xiaoyan Ding; Wei Liu; Yue-Lei Chen
Journal:  J Mol Med (Berl)       Date:  2016-06-24       Impact factor: 4.599

10.  Use of Hyaluronic Acid-Based Biological Bilaminar Matrix in Wound Bed Preparation: A Case Series.

Authors:  Richard Simman; Walid Mari; Sara Younes; Michael Wilson
Journal:  Eplasty       Date:  2018-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.